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Arterial Stiffness, Physical Activity, and 
Atrial Natriuretic Peptide Gene 
Polymorphism in Older Subjects
Motoyuki IEMITSU1),2), Seiji MAEDA1),2), Takeshi OTSUKI1), Jun SUGAWARA3), 
Shinya KUNO2), Ryuichi AJISAKA2), and Mitsuo MATSUDA1)
An increase in arterial stiffness with advancing age is associated with several pathological states, including
hypertension and arteriosclerosis. Regular exercise improves the aging-induced increase in arterial stiff-
ness and has a protective effect against these diseases. However, not all individuals respond to exercise
to the same extent. Atrial natriuretic peptide (ANP) is involved in the regulation of basal blood pressure,
blood flow, and vascular tone. The present study was designed to clarify whether gene polymorphisms in
ANP-related genes affect exercise-induced improvements in arterial stiffness. We performed a cross-sec-
tional study of 291 healthy middle-aged and older Japanese subjects (63±1 years), examining the relation-
ship between daily physical activity–induced improvements in arterial stiffness, estimated by brachial-ankle
arterial pulse wave velocity (baPWV), and the gene polymorphisms of valine32methionine (V32M: 664G>A)
in exon 1 of ANP and asparagine521aspartic acid (N521D: 1780A>G) in exon 8 of the ANP clearance receptor
(NPR-C). The baseline baPWV was significantly lower in the active group, but no differences were seen in
blood pressure. Active subjects with the ANP-VV genotype had significantly lower baPWV and higher
plasma ANP levels compared with inactive subjects, but there were no variations related to the VM+MM
genotype. Additionally, baPWV and plasma ANP levels were negatively correlated in ANP-VV genotype
subjects, but were not correlated in VM+MM individuals. Our results suggest that ANP polymorphism
in older Japanese subjects may affect the cardiovascular response to regular exercise. (Hypertens Res
2008; 31: 767–774)
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Introduction
The central arteries, the aorta and large arteries, have a buff-
ering action to level off fluctuations in blood pressure created
by cardiac pulsation, thereby supplying a relatively constant
blood flow to the tissues and organs. Increases in arterial stiff-
ness impair this buffering ability, leading to a rise in systolic
blood pressure (SBP) and left ventricular afterload. In seden-
tary healthy humans, arterial stiffness of the central circula-
tion increases with advancing age (1, 2). The age-related
increase in arterial stiffness is associated with the develop-
ment of several pathological conditions, including hyperten-
sion, atherosclerosis, congestive heart failure, stroke, and
aortic root regurgitation (3–6). Therefore, increased arterial
stiffness may be an independent risk factor for all-cause mor-
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tality and the development of cardiovascular disorders (3, 4).
Several cross-sectional studies have clearly demonstrated that
arterial stiffness is lower in physically active individuals com-
pared with sedentary individuals (2, 7–9). Furthermore, aero-
bic exercise training intervention has been shown to attenuate
age-related increases in arterial stiffness (9, 10). Thus, habit-
ual exercise prevents and/or reverses the increases in arterial
stiffness with advancing age.
The natriuretic peptide system is thought to play roles in the
regulation of blood pressure, body fluid homeostasis, and vas-
cular remodeling (11–13). The natriuretic peptides consist of
three endogenous ligands, atrial natriuretic peptide (ANP),
brain natriuretic peptide (BNP), and C-type natriuretic pep-
tide (CNP) (11, 14), and their activity is mediated by at least
three different receptors: natriuretic peptide receptor (NPR)-
A, NPR-B, and ANP clearance receptor (NPR-C) (11, 15).
ANP, primarily secreted from the atrium of the heart, regu-
lates basal blood pressure, blood flow, vascular volume and
tone, and arterial stiffness (12, 16–18). Variations in ANP
genetic sequence were recently found to be associated with
differences in the development of cardiovascular disease and
related conditions such as hypertension, stroke, and hyper-
cholesterolemia (19–22). However, the relationship between
genetic variations in ANP and exercise-induced improve-
ments in arterial stiffness remains unclear.
Because ANP is implicated in the regulation of arterial
stiffness, we hypothesized that genetic variations in ANP
could affect the exercise-induced reduction in arterial stiff-
ness in human subjects. Thus, we examined whether poly-
morphisms in the ANP genes affected the degree of change in
arterial stiffness following exercise in middle-aged and older
human subjects. Additionally, as another target gene, we
examined gene polymorphisms in NPR-C, the ANP clearance
receptor. In the present study, we tested our hypothesis by
assessing the daily physical activity, arterial stiffness, and
genotypes of single-nucleotide polymorphisms (SNPs) of
valine32methionine (V32M: 664G>A) in exon 1 of ANP on
chromosome 1 and asparagine521aspartic acid (N521D:
1780A>G) in exon 8 of NPR-C on chromosome 5 in healthy
middle-aged and older Japanese subjects. In the present study,
the SNPs were picked up from the JSNP (a database of Japa-
nese Single Nucleotide Polymorphisms) public database (23,
24), which constitutes a potent infrastructure for the next step
toward personalized medicine, i.e., whole-genome associa-
tion studies of common diseases or drug sensitivities in Japa-
nese individuals. We measured brachial-ankle arterial pulse
wave velocity (baPWV) as an index of arterial stiffness (25).
Finally, the plasma ANP level was determined in different
study groups.
Methods
Subjects
Two hundred and ninety-one middle-aged and older Japanese
subjects (85 males and 206 females) between 51 and 78 years
of age participated in this cross-sectional study (mean: 63±1
years). Subjects were divided into inactive lifestyle (Inactive)
and active lifestyle (Active) groups, with the dividing line set
at the median value (216 kcal/d) of mean energy expenditure
per day. Subjects were recruited for the present study by
advertisement. All subjects were free of any overt signs and
symptoms of chronic diseases. None of the participants had a
history of smoking, and none were currently taking medica-
tions. SBP, diastolic blood pressure (DBP), heart rate (HR),
baPWV, daily physical activity, polymorphisms in ANP and
NPR-C genes, and plasma ANP levels were determined in all
subjects in the same season. Serum cholesterol, triglycerides,
and insulin, and plasma glucose levels were also measured.
All of the female subjects were postmenopausal women.
The study was approved by the Ethical Committees of the
Institute of Health and Sport Sciences and the Institute of
Clinical Medicine of the University of Tsukuba. All subjects
gave written informed consent to participate before inclusion
in the study.
Measurement of Daily Physical Activity
Daily physical activity was measured using a uniaxial accel-
erometer (Life-Corder; Suzuken Co., Nagoya, Japan) as
described in previous studies (8). All subjects wore the uniax-
ial accelerometer on the waist continuously for 14 d, except
for sleeping and bathing, and data from a continuous 7-d
period was used to assess physical activity. The total energy
expenditure (kcal) was calculated as the sum of the energy
measured by both the uniaxial accelerometer and the ques-
tionnaire of activities with the Compendium of Physical
Activity (26).
Measurement of Arterial Pulse Wave Velocity
baPWV (using formPWV/ABI; Colin Medical Technology,
Komaki, Japan) was measured as previously described (8, 25)
The baPWV value reflects the degree of stiffness in the cen-
tral arteries, and baPWV correlates well with the aortic pulse
wave velocity (PWV) measured using a catheter tip with pres-
sure manometer (25).
SNP Genotyping
Genomic DNA was extracted from plasma buffy coats and
buccal cells using the QIAamp DNA Blood Maxi Kit
(QIAGEN, Tokyo, Japan). ANP and NPR-C SNP genotypes
were determined by real-time PCR with TaqMan probes
using an ABI Prism 7700 Sequence Detector (Perkin-Elmer
Applied Biosystems, Foster, USA) as previously described
with minor modifications (8). The gene-specific primers and
TaqMan probes for each SNP were synthesized using Primer
Express v.1.5 software (Perkin-Elmer Applied Biosystems)
according to the published DNA sequences for each SNP as
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follows: V32M in exon 1 of ANP (NCBI accession #rs5063)
and N521D in exon 8 of NPR-C (NCBI accession
#rs2270915). The sequences of the oligonucleotides used are
as follows: ANP forward: 5′-TCAGACCAGAGCTAATCC
CATGTA-3′; ANP reverse: 5′-GGCCCTACCTTGAAATCC
ATCAG-3′; ANP/G probe: 5′-AATGCCGTGTCCAAC-3′;
ANP/A probe: 5′-CAATGCCATGTCCAAC-3′; NPR-C for-
ward: 5′-CCATTGAGAGGCGAACCCA-3′; NPR-C
reverse: 5′-TCTTCCCGTAATTCCCGATGTTTTC-3′;
NPR-C/A probe: 5′-AAGAAGAAAGTAACCTTG-3′; NPR-
C/G probe: 5′-AAGAAGAAAGTGACCTTG-3′.
PCR 96-well plates were read on an ABI-7700 using the
end-point analysis mode of the SDS v1.7a software package
(Perkin-Elmer Applied Biosystems). Genotypes were deter-
mined automatically by the single processing algorithms in
the software package.
Measurements of Serum Cholesterol, Triglycer-
ides, and Insulin Levels, and Plasma ANP and
Glucose Levels
Fasting serum concentrations of cholesterol, triglycerides,
and insulin, and plasma concentrations of glucose were deter-
mined using standard enzymatic techniques. Plasma ANP
concentrations were determined using a sandwich-EIA Kit
(Phoenix Pharmaceuticals Inc., Belmont, USA) for ANP. The
reported cross-reactivity for the antibody was 0% for BNP
and 0% for CNP.
Statistical Analysis
The ANP and NPR-C allelic frequencies were calculated
using a gene-counting method, and Hardy-Weinberg equilib-
rium was confirmed using a χ2 test. Student’s t-test for
unpaired values was used to evaluate differences between
active and inactive groups or differences among the different
genotype groups. Values of p<0.05 were considered statisti-
cally significant. Furthermore, the PWV comparisons
between the genotype groups in each active and inactive
group were assessed by a covariance analysis (ANCOVA)
model that included age, SBP, and sex as covariates. Unless
indicated otherwise, values of p<0.05 were considered statis-
tically significant. Because of the multiple comparisons of
genotypes, we applied Bonferroni correction. Since we exam-
ined three genotypes, we divided 0.05 by 3 to get 0.0167.
Thus, values of p<0.0167 were considered statistically sig-
nificant. Values are expressed as the means±SEM.
Results
Comparison of Characteristics in Low and High
Physical Activity Groups
We examined 291 individuals in a cross-sectional study com-
paring physical activity levels, arterial stiffness, and ANP and
NPR-C genotype, and the subject characteristics are shown in
Table 1. In the active group, the mean baPWV, a measure that
directly correlates with arterial stiffness, was significantly
lower than that of the inactive group. There were no signifi-
cant differences in body mass index (BMI), SBP, DBP, total
cholesterol, high-density lipoprotein (HDL), triglycerides,
insulin, and glucose between the active and inactive groups.
HR and low-density lipoprotein (LDL) were significantly
lower in the active group than in the inactive group.
Table 1. Characteristics of Subjects in the Active and Inac-
tive Groups
Active Inactive
Number of subjects 146 145
Age, years 63±1* 64±1
Body weight, kg 58±1* 54±1
Height, cm 158±1* 154±1
Body mass index, kg/m2 23.9±0.2 23.5±0.2
Systolic blood pressure, mmHg 125±1 128±2
Diastolic blood pressure, mmHg 78±1 77±1
Heart rate, beats/min 60±1* 63±1
Total cholesterol, mg/dL 215±3 224±3
HDL cholesterol, mg/dL 62±1 63±1
LDL cholesterol, mg/dL 127±3* 134±2
Triglycerides, mg/dL 96±4 101±5
Insulin, μU/mL 5.3±0.3 6.0±0.3
Glucose, mg/dL 99±1 98±1
Pulse wave velocity, cm/s 1,453±18* 1,510±21
Daily physical activity, kcal/day 360±12* 148±4
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Values are means±SEM. *p<0.05 vs. Inactive.
Table 2. Distribution of Gene Polymorphisms of ANP
(V32M) and NPR-C (N521D) and Allele Frequency in the
Study Subjects
Total Male Female
Genotypes, % (n)
ANP VV 82.8 (241) 87.1 (74) 81.1 (167)
VM 15.8 (46) 10.6 (9) 18.0 (37)
MM 1.2 (4) 2.1 (2) 0.8 (2)
NPR-C NN 63.6 (185) 67.9 (57) 61.8 (128)
ND 32.6 (95) 29.8 (25) 33.8 (70)
DD 2.8 (11) 1.8 (2) 3.1 (9)
Allele frequency
ANP (M allele) 0.09 0.08 0.10
NPR-C (D allele) 0.20 0.17 0.21
ANP, atrial natriuretic peptide; NPR-C, ANP clearance receptor.
The genotype frequencies did not deviate from Hardy-Weinberg
equilibrium. No difference was found between genders.
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Comparison of Characteristics between Each
Genotype
We analyzed the ANP and NPR-C genotypes of the study
subjects (Table 2), and no significant differences in the fre-
quency of these polymorphisms were found between genders.
Additionally, the allelic frequencies did not deviate from the
expected Hardy-Weinberg equilibrium.
We next compared the characteristics of subjects with dif-
ferent gene polymorphisms (Table 3). In the genotypes of
V32M of ANP, SBP, DBP, and baPWV were significantly
lower in the VM+MM group than the VV group. There were
no significant differences in daily physical activity, body
weight, height, BMI, HR, total cholesterol, HDL, LDL, tri-
glycerides, insulin, and glucose between these groups. In the
genotypes of N521D of NPR-C, there were no significant dif-
ferences in any parameters between the NN and ND+DD
groups.
Comparison of PWV and Plasma ANP Levels
between Genotypes and Physical Activity
The baPWV values of subjects with the VV genotype of
V32M of ANP or the NN genotype of N521D of NPR-C were
significantly lower in the active group compared with the
inactive group, but no significant differences were seen in the
baPWV of subjects with the VM+MM of ANP or ND+DD
of NPR-C genotypes (Fig. 1). Additionally, the plasma ANP
concentrations of subjects with the VV genotype of V32M of
ANP or the NN genotype of N521D of NPR-C were higher in
the active group compared with the inactive group, and there
was no significant difference in plasma ANP levels for indi-
viduals with the VM+MM of ANP or ND+DD of NPR-C
genotypes regardless of physical activity (Fig. 2). To further
explore a possible relationship between arterial stiffness and
plasma ANP levels, we performed regression analyses
between baPWV and plasma ANP level. There were negative
and significant correlations between baPWV and plasma
ANP level in all the study subjects (y=−4.9x + 1,669, r=0.26,
p<0.01). In the genotypes of V32M of ANP, there was a neg-
ative and significant correlation between baPWV and the
plasma ANP level of the individuals with the VV genotype
(Fig. 3A). There was no significant correlation observed for
the VM+MM genotype (Fig. 3B), however. Additionally,
baPWV and the plasma ANP level of individuals with both
genotypes of N521D of NPR-C were significantly correlated
(Fig. 3C and D). Interestingly, the slopes of the regression
lines were significantly different between the genotypes of
ANP (p<0.05), but not significantly different between the
genotypes of NPR-C. Moreover, we performed a multivariate
analysis between baPWV and body weight, height, SBP,
DBP, HR, total cholesterol, HDL, LDL, triglycerides, insulin,
glucose, daily physical activity, sex, and plasma ANP level by
using stepwise multivariable regression models in each geno-
type of ANP. In the stepwise multivariable regression models,
baPWV in the VV group remained, and was associated with
DBP and the plasma ANP level. On the other hand, in the
VM+MM group, baPWV remained, and was associated with
SBP, DBP and body weight.
Discussion
The principle findings of the present cross-sectional study
were the relationships among arterial stiffness, physical activ-
Table 3. Genotypes of ANP (V32M) and NPR-C (N521D) and Subject Characteristics
ANP (V32M) NPR-C (N521D)
VV VM+MM NN ND+DD
Age, years 64±1 60±1* 63±1 64±1
Body weight, kg 56±1 56±1 56±1 55±1
Height, cm 156±1 157±1 156±1 155±1
Body mass index, kg/m2 23.7±0.2 23.3±0.4 23.7±0.2 23.5±0.3
Systolic blood pressure, mmHg 127±1 120±2* 126±1 127±2
Diastolic blood pressure, mmHg 78±1 73±1* 77±1 77±1
Heart rate, beats/min 62±1 61±1 61±1 62±1
Total cholesterol, mg/dL 220±2 216±5 222±3 216±3
HDL cholesterol, mg/dL 62±1 65±2 63±1 62±1
LDL cholesterol, mg/dL 131±2 125±5 132±2 126±3
Triglycerides, mg/dL 99±3 91±7 97±3 97±5
Insulin, μU/mL 5.8±0.3 5.4±0.4 5.3±0.2 6.4±0.5
Glucose, mg/dL 99±1 97±2 99±1 97±2
Daily physical activity, kcal/d 251±9 250±23 257±11 245±14
Pulse wave velocity, cm/s 1,497±15 1,380±26* 1,470±17 1,485±23
ANP, atrial natriuretic peptide; NPR-C, ANP clearance receptor; HDL, high-density lipoprotein; LDL, low-density lipoprotein. Values
are means±SEM. *p<0.05 vs. VV genotype of ANP (V32M).
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ity, and polymorphisms in ANP genes in Japanese middle-
aged and older human subjects. Interestingly, using baPWV
as a measure of arterial stiffness, increased physical activity
in individuals with the VV genotype at V32M (664G/A) of
the ANP gene decreased arterial stiffness, but there was no
effect of exercise on arterial stiffness in individuals with the
VM+MM genotype. In contrast, when polymorphisms of
NPR-C were examined, N521D (1780A/G) had no effect on
the changes in arterial stiffness following the prescribed exer-
cise. Thus, genetic polymorphisms in components of the ANP
pathway may differentially affect changes in age-related arte-
rial stiffness in response to habitual exercise.
Several studies have reported that arterial stiffness is lower
in physically active individuals compared with sedentary
individuals (2, 7–9). In regard to the mechanism, it is well
known that habitual exercise induces activation of vasodilat-
ing factors, e.g., nitric oxide, in older humans (27). Rogers et
al. (28) reported that exercise training increased plasma ANP
Fig. 1. Brachial-ankle PWV (baPWV) values for each geno-
type of the ANP (V32M) (A) and NPR-C (N521D) (B) gene
polymorphisms of subjects in the cross-sectional study. Sub-
jects were divided into inactive lifestyle (Inactive: open bar)
or active lifestyle (Active: solid bar) groups using the median
value (216 kcal/d) of energy expenditure per day as a cut-off.
Differences in PWV between each genotype in the Active and
the Inactive groups were assessed by a covariance analysis
(ANCOVA) model that included age, systolic blood pressure
(SBP), and sex as covariates. Data are expressed as the
means±SEM.
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levels at rest. In healthy humans, ANP regulates basal blood
pressure, blood flow, and vascular volume and tone (12, 13,
16, 17). After binding to its specific receptor(s), ANP
increases cellular concentrations of cyclic guanosine mono-
phosphate (cGMP) by activation of a receptor-coupled gua-
nylate cyclase (29). We showed that plasma ANP levels
negatively correlate with arterial stiffness. Thus, ANP may
participate in a mechanism of physical activity–related
change in PWV. Interestingly, the plasma ANP levels of indi-
viduals with the VV genotype of V32M of ANP did correlate
with arterial stiffness, but this was not seen in subjects with
the VM+MM genotype. Additionally, this correlation was
independent of the examined polymorphism in NRP-C. The
V32M polymorphism is located in exon 1 of the ANP gene,
and it resides in a structural region of the gene. Thus, varia-
tions in this location could affect the regulation of gene
expression, mRNA stability, and/or ANP translation. Alterna-
tively, changes in the coding region of ANP could alter its
receptor binding characteristics and downstream activity.
Collectively, polymorphisms in different components of the
ANP system may differentially affect various functional
aspects of this system, such as changes in the plasma ANP
level, differences in ligand-binding affinity, and intracellular
cGMP production via the ANP pathway. However, there is no
clear reason to link the genotype of the ANP gene to physical
activity–related changes in baPWV. Future studies should
clarify this issue and examine the functional effect of the
ANP genotype on the relationship between arterial stiffness
and regular exercise.
Arterial infusion of exogenous ANP decreased PWV with-
out affecting mean blood pressure and HR, and infusion of
A71915, a selective NRP-A antagonist, increased PWV in an
animal study in vivo (18). These data suggest that the ANP
system is associated with regulation of basal arterial stiffness.
In the present study, regular exercise abrogated the age-
related increase in arterial stiffness of subjects with the VV
genotype of V32M of ANP. The mechanism by which this
polymorphism affects the ability of exercise to decrease arte-
rial stiffness remains unclear, but this finding further supports
the importance of ANP in modulating the arterial-buffering
function. In contrast, changes in arterial distensibility follow-
ing the introduction of an exercise regimen were not affected
by polymorphisms in NPR-C. Additionally, the negative cor-
relation between arterial stiffness and plasma ANP levels was
seen in both NPR-C genotypes. Thus, the examined NPR-C
polymorphism does not seem to affect the relationship
between changes in plasma ANP and reductions in age-
related arterial stiffness following regular exercise.
In the present study, we selected the polymorphisms of
V32M in the ANP gene and N521D in NPR-C to investigate
Fig. 3. The relations between brachial-ankle PWV (baPWV) and plasma ANP levels of subjects with each genotype of the ANP
(V32M) (A: VV; B: VM+MM) and NPR-C (N521D) (C: NN; D: ND+DD) gene polymorphisms.
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the effect of genotypes in the ANP system on the relationship
between arterial stiffness and regular exercise. However,
there may be other important polymorphisms in other regions
of the ANP gene or NPR-C gene. We performed our linkage
analysis by using a linkage disequilibrium map from the
International HapMap Project (http://www.hapmap.org/
index.html.en) (30) to research common genetic variants of
V32M in the ANP gene or N521D in the NPR-C gene. How-
ever, there was no SNP which linked genetic variants to
V32M in the ANP gene. A previous report identified associa-
tions between polymorphism in the exon 3 region of the ANP
gene, e.g., stop152arginine (2238T>C: rs5065), and cardio-
vascular disease (20). We confirmed the effect of this poly-
morphism in the present study, but the allele frequency of
stop152arginine was 98% in stop codon genotype. We did not
observe any relationship between this polymorphism and the
effect of exercise on changes in arterial stiffness in middle-
aged and older subjects (data not shown). Additionally, the
linkage to N521D in the NPR-C gene was detected at
rs2246427 A>G and rs3811953 G>A; however, there were
two SNPs in the intron region. Therefore, it is considered that
the two polymorphisms selected in the present study, V32M
in the ANP gene and N521D in the NPR-C gene, may be
important genotypes in the ANP system that effect the rela-
tionship between arterial stiffness and regular exercise. How-
ever, more genotypes in different positions of the ANP gene
or NPR-C gene should be evaluated for their role in regulat-
ing vascular tone under sedentary and active conditions. In
addition, our study examined only Japanese subjects, and thus
our data cannot be used to address differences in ANP and
NPR-C polymorphisms in other ethnic groups.
The present results showed that age-related changes in
SBP, DBP and baPWV were lower in patients with the
VM+MM genotype of ANP than in those with the VV geno-
type. Although the comparisons of SBP, DBP and baPWV
between the genotype groups were assessed by an ANCOVA
model that included age as a covariate, these differences were
not changed. However, the difference of age may have
affected these relationships between polymorphism and SBP,
DBP or baPWV. Thus, future studies should clarify this issue
and examine the effect of age on SBP, DBP and baPWV in
different genotypes in ANP. Secondly, the sample size in the
present study was relatively small. In the future, it will be
important to investigate various polymorphisms in ANP and
NPR-C using a much larger number of Japanese subjects in
the current experimental setting. Finally, although the present
study revealed that ANP polymorphism affected exercise-
induced improvements in arterial stiffness, these results may
have been affected by diets. Future studies will be needed to
clarify this issue and to examine the effect of diet on the rela-
tionship between polymorphisms in ANP and NPR-C and
arterial stiffness and regular exercise.
In conclusion, we investigated the relationship of polymor-
phisms in ANP and NPR-C with arterial stiffness and regular
exercise. We identified the V32M molecular variant in exon 1
of the ANP gene as a polymorphism affecting the improve-
ment of arterial stiffness following habitual exercise. Further-
more, the V32M polymorphism of ANP affected the
relationship between arterial stiffness and circulating ANP
level. However, the N521D polymorphism in exon 8 of NPR-
C did not affect the exercise-associated changes in arterial
stiffness. Thus, molecular variations in the ANP gene affect
the cardiovascular response to regular exercise in middle-
aged and older subjects. These effects could be important for
health promotion and the development of strategies to prevent
cardiovascular diseases.
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